![Julian Hanak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julian Hanak formerly worked at Purespring Therapeutics Ltd., as Chief Executive Officer from 2022 to 2025, NightstaRx Ltd., as Director from 2017 to 2019, and Novasep Holding SAS, as Member-Supervisory Board.
| Sociétés | Poste | Fin |
|---|---|---|
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Directeur Général | 12/03/2025 |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Directeur/Membre du Conseil | 07/06/2019 |
Novasep Holding SAS
 Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Manufactures fine and agro chemicals & biopharmaceuticals products | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Novasep Holding SAS
Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Manufactures fine and agro chemicals & biopharmaceuticals products | Process Industries |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Health Services |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
